Alpine Global Management’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-242
Closed -$534K 71
2018
Q1
$534K Buy
+242
New +$616K 0.13% 70
2017
Q3
Sell
-301
Closed -$410K 198
2017
Q2
$410K Buy
+301
New +$363K 0.13% 69
2015
Q3
Sell
-10
Closed -$21K 182
2015
Q2
$21K Buy
+10
New +$20.4K ﹤0.01% 920

Other funds holding BLUE

Alpine Global Management's BLUE Position: Q2 2018 in Review

Alpine Global Management sold out of bluebird bio (BLUE) in Q2 2018, closing a stake of 242 shares — an estimated $534K sold.

Alpine Global Management first reported a position in BLUE in Q2 2015 and held it in 3 quarters. The position peaked at $534K in Q1 2018. 307 funds tracked by Wall St. Rank hold BLUE as of Q2 2018.

  • Alpine Global Management reported no remaining bluebird bio position as of Q2 2018 after selling out during the quarter.
  • Alpine Global Management sold 242 bluebird bio shares in Q2 2018, an estimated $534K.
  • Alpine Global Management first reported a position in bluebird bio in Q2 2015 and held it in 3 quarters.
  • Alpine Global Management's bluebird bio position peaked at $534K in Q1 2018.
  • 307 funds tracked by Wall St. Rank held bluebird bio as of Q2 2018.

Based on Alpine Global Management's 13F filing for Q2 2018, filed 15 Aug 2018.